Loading stock data…
NATR
$20.14+0.38 (+1.92%)
After Hours$20.14+0.00 (+0.00%)· Last close Jun 9
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Nature's Sunshine Products, Inc. in the Consumer Defensive sector is trading at $20.14 with a market capitalization of $350M. Wall Street consensus targets $35.00 (2 analysts), implying a +73.8% move over the next 12 months. The stock is currently 28% below its 52-week high of $28.14, remaining 6.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +73.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 28) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$20.14
Potential Upside
14.3%
Whystock Fair Value$23.03
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$349.94M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
18.09
Beta
Defensive asset. Lower volatility than the S&P 500.
0.95
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.92%
Volume
Today's trading volume
96,992
Recent News
How The Story Around Nature’s Sunshine (NATR) Is Shifting After Q4 And New Analyst Targets
Analysts have recently raised their price targets for Nature's Sunshine Products while the model fair value stays put at US$35.00 per share, keeping the central valuation anchor unchanged. These higher targets are being linked to Q4 results that topped earlier expectations, broad regional strength, growing digital traction, and the view that the product portfolio is still under-penetrated in several key markets. Ahead, you will see how to track this evolving narrative and what to watch as...
How The Nature’s Sunshine (NATR) Narrative Is Shifting With Q4 Beats And Digital Growth
The updated analyst narrative for Nature's Sunshine Products comes with a slightly higher fair value price target, moving from US$33 to US$35.00. That shift is tied to bullish analysts pointing to Q4 results coming in comfortably above consensus, a recurring "beat and raise" pattern, and what they see as ongoing opportunities in under penetrated markets and digital channels. As you read on, you will see how these views are evolving and what to watch if you are tracking this story...
Discovering US Undiscovered Gems in May 2026
The United States market has experienced a flat performance over the last week, yet it has seen a significant 24% increase over the past year with earnings projected to grow by 17% annually. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering undiscovered gems that may offer opportunities for investors.
NATR Q1 Deep Dive: Digital Channel Expansion and Margin Gains Shape Outlook
Wellness products company Nature’s Sunshine (NASDAQ:NATR) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 8.5% year on year to $122.9 million. The company expects the full year’s revenue to be around $507.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.30 per share was 46.3% above analysts’ consensus estimates.
Nature's Sunshine Products, Inc. Just Beat EPS By 41%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that Nature's Sunshine Products, Inc. ( NASDAQ:NATR ) released its quarterly result to...